Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.
Human Factors and Medical Devices.
Human Factors Engineering Team, Center for Devices and Radiological Health, Office of Communication, Education, and Radiation Programs (OCER), Division of Device User Programs and Systems Analysis (DDUPSA), 1350 Piccard Drive, HFZ-230, Rockville, MD 20850.
Action needed to prevent dangerous heparin-insulin confusion.
ISMP Medication Safety Alert! Acute Care Edition. May 3, 2007;12:1-2.
Preventing Medical Errors.
Food and Drug Administration (FDA) Patient Safety News. Show #79. September 2008.
COMMENTARYView all related resources...
Preparing your hospital for compliance with The Joint Commission's National Patient Safety Goals.
Murdaugh L, Jordin R. Hosp Pharm. 2008;43:728-733.